Literature DB >> 8367494

Design of peptide enzymes (pepzymes): surface-simulation synthetic peptides that mimic the chymotrypsin and trypsin active sites exhibit the activity and specificity of the respective enzyme.

M Z Atassi1, T Manshouri.   

Abstract

Two 29-residue peptides were prepared, one of which (ChPepz) was designed by surface-simulation synthesis to mimic the active site of alpha-chymotrypsin, and the other (TrPepz), which contained four substitutions relative to ChPepz, was fashioned after the active site of trypsin. Each peptide was cyclized by a disulfide bond. The ChPepz monomer effected hydrolysis of the ester group in N-benzoyl-L-tyrosine ethyl ester, an alpha-chymotrypsin substrate, with Km and kcat values that were comparable to those of alpha-chymotrypsin. ChPepz was completely inactivated by diisopropyl fluorophosphate (DIFP), L-1-p-tosylamino-2-phenylethyl chloromethyl ketone (TPCK), or reduction of the disulfide bond. It had no catalytic activity on N-tosyl-L-arginine methyl ester, a trypsin substrate. On the other hand, TrPepz, which had no effect on N-benzoyl-L-tyrosine ethyl ester, hydrolyzed N-tosyl-L-arginine methyl ester with a Km value that was essentially identical to that of trypsin, but its kcat value was almost half that of trypsin. TrPepz was fully inactivated by reduction of the disulfide bond, by DIFP, or by phenylmethylsulfonyl fluoride but not by TPCK. It was also completely inhibited by soybean trypsin inhibitor, bovine pancreatic trypsin inhibitor, and human alpha 1-antitrypsin. ChPepz and TrPepz hydrolyzed proteins (myoglobin and casein) to give panels of peptides that were similar to those of the same protein obtained with the respective enzyme. However, TrPepz was more efficient than trypsin at hydrolyzing the C bonds of two or more consecutive lysine and/or arginine residues. Like its esterase activity, the proteolytic activity of ChPepz was inhibited by either DIFP or TPCK whereas that of TrPepz was inhibited by either DIFP or phenylmethylsulfonyl fluoride but not by TPCK. Finally, ChPepz and TrPepz were each more active at low temperature than the respective enzyme. This ability to construct fully functional peptide enzymes (pepzymes) of chosen specificities should find many practical applications.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8367494      PMCID: PMC47333          DOI: 10.1073/pnas.90.17.8282

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

Review 1.  Catalytic antibodies.

Authors:  K M Shokat; P G Schultz
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

2.  Design and synthesis of a peptide having chymotrypsin-like esterase activity.

Authors:  K W Hahn; W A Klis; J M Stewart
Journal:  Science       Date:  1990-06-22       Impact factor: 47.728

3.  Catalytic antibodies with lipase activity and R or S substrate selectivity.

Authors:  K D Janda; S J Benkovic; R A Lerner
Journal:  Science       Date:  1989-04-28       Impact factor: 47.728

4.  Selective chemical catalysis by an antibody.

Authors:  S J Pollack; J W Jacobs; P G Schultz
Journal:  Science       Date:  1986-12-19       Impact factor: 47.728

5.  Generation of a catalytic antibody by site-directed mutagenesis.

Authors:  E Baldwin; P G Schultz
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

6.  Localization and synthesis of the hormone-binding regions of the human thyrotropin receptor.

Authors:  M Z Atassi; T Manshouri; S Sakata
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

7.  Structure of alpha-chymotrypsin refined at 1.68 A resolution.

Authors:  H Tsukada; D M Blow
Journal:  J Mol Biol       Date:  1985-08-20       Impact factor: 5.469

8.  Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease.

Authors:  J Schneider; S B Kent
Journal:  Cell       Date:  1988-07-29       Impact factor: 41.582

9.  Surface-simulation synthesis of the substrate-binding site of an enzyme. Demonstration with trypsin.

Authors:  M Z Atassi
Journal:  Biochem J       Date:  1985-03-01       Impact factor: 3.857

10.  Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution.

Authors:  M Miller; J Schneider; B K Sathyanarayana; M V Toth; G R Marshall; L Clawson; L Selk; S B Kent; A Wlodawer
Journal:  Science       Date:  1989-12-01       Impact factor: 47.728

View more
  13 in total

1.  Synthesis of functionalised nucleosides for incorporation into nucleic acid-based serine protease mimics.

Authors:  Mieke A Catry; Annemieke Madder
Journal:  Molecules       Date:  2007-01-31       Impact factor: 4.411

Review 2.  On the failure of de novo-designed peptides as biocatalysts.

Authors:  M J Corey; E Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

3.  Cyclic peptides as proteases: a reevaluation.

Authors:  D R Corey; M A Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

Review 4.  Can small cyclic peptides have the activity and specificity of proteolytic enzymes?

Authors:  B W Matthews; C S Craik; H Neurath
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

Review 5.  Hapten design for the generation of catalytic antibodies.

Authors:  N R Thomas
Journal:  Appl Biochem Biotechnol       Date:  1994 May-Jun       Impact factor: 2.926

6.  Structure of a cyclic peptide with a catalytic triad, determined by computer simulation and NMR spectroscopy.

Authors:  B Walse; M Ullner; C Lindbladh; L Bülow; T Drakenberg; O Teleman
Journal:  J Comput Aided Mol Des       Date:  1996-02       Impact factor: 3.686

7.  Synthesis and conformational analysis by 1H NMR and restrained molecular dynamics simulations of the cyclic decapeptide [Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly].

Authors:  R A Buono; N Kucharczyk; M Neuenschwander; J Kemmink; L Y Hwang; J L Fauchère; C A Venanzi
Journal:  J Comput Aided Mol Des       Date:  1996-06       Impact factor: 3.686

8.  A reinvestigation of a synthetic peptide (TrPepz) designed to mimic trypsin.

Authors:  J A Wells; W J Fairbrother; J Otlewski; M Laskowski; J Burnier
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

9.  Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin.

Authors:  Michael Brines; Nimesh S A Patel; Pia Villa; Courtenay Brines; Tiziana Mennini; Massimiliano De Paola; Zubeyde Erbayraktar; Serhat Erbayraktar; Bruno Sepodes; Christoph Thiemermann; Pietro Ghezzi; Michael Yamin; Carla C Hand; Qiao-wen Xie; Thomas Coleman; Anthony Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-01       Impact factor: 11.205

Review 10.  On the free energy that drove primordial anabolism.

Authors:  Michael Kaufmann
Journal:  Int J Mol Sci       Date:  2009-04-22       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.